…
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 7, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 | 2021-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 | 2021-02-28 |
| Income before tax | -298.08M | -146.99M | -36.43M | -42.30M | -50.79M |
| Minority interest | 10.81M | - | - | - | -2.65M |
| Net income | -236.12M | -110.27M | -26.73M | -33.75M | -42.62M |
| Selling general administrative | 37.27M | - | 9.74M | 7.96M | 7.63M |
| Selling and marketing expenses | 10.94M | - | 5.22M | 1.07M | - |
| Gross profit | -28.06M | 10.07M | 4.00M | -0.78M | -0.92M |
| Reconciled depreciation | 62.56M | - | 5.41M | 5.52M | 4.74M |
| Ebit | -216.96M | -135.10M | -31.90M | -38.09M | -46.56M |
| Ebitda | -154.40M | -114.39M | -26.49M | -32.57M | -41.82M |
| Depreciation and amortization | 62.56M | 20.71M | 5.41M | 5.52M | 4.74M |
| Operating income | -227.74M | -135.10M | -35.52M | -38.36M | -46.77M |
| Other operating expenses | 279.86M | 164.05M | 61.76M | 44.57M | 40.39M |
| Interest expense | 81.12M | - | 4.58M | 4.22M | 4.69M |
| Tax provision | -51.15M | - | -9.71M | -8.55M | -8.17M |
| Interest income | 10.78M | - | 3.37M | 0.28M | 0.67M |
| Net interest income | -70.33M | - | -0.91M | -3.94M | -4.02M |
| Income tax expense | -51.15M | 37.20M | -9.71M | -8.55M | -8.17M |
| Total revenue | 52.11M | 28.95M | 12.69M | 2.64M | 1.93M |
| Total operating expenses | 199.68M | 145.16M | 53.08M | 41.16M | 37.54M |
| Cost of revenue | 80.17M | 18.89M | 8.68M | 3.41M | 2.84M |
| Total other income expense net | -70.33M | -11.89M | -0.91M | -3.94M | -4.02M |
| Net income from continuing ops | -246.93M | - | -26.73M | -33.75M | -42.62M |
| Net income applicable to common shares | -236.12M | - | -26.73M | -33.75M | -42.62M |
| Breakdown | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 | 2021-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 | 2021-02-28 |
| Total assets | 2349.17M | 2709.13M | 1900.88M | 1164.69M | 780.36M |
| Intangible assets | 24.30M | 82.21M | 24.41M | 16.89M | 3.16M |
| Other current assets | 73.20M | 87.30M | - | - | 16.14M |
| Total liab | 1234.57M | 1388.02M | 1060.68M | 878.38M | 573.95M |
| Total stockholder equity | 1038.63M | 1243.65M | 840.20M | 286.31M | 206.41M |
| Deferred long term liab | - | - | - | 13.00M | - |
| Other current liab | 26.21M | 1.81M | 23.64M | 16.65M | 25.50M |
| Common stock | 1210.30M | 1170.06M | 1134.75M | 563.88M | 453.08M |
| Capital stock | 1210.30M | - | 1134.75M | 563.88M | 453.08M |
| Retained earnings | -198.93M | 46.52M | -316.24M | -289.52M | -255.77M |
| Other liab | - | - | - | - | 4.00M |
| Other assets | - | - | - | 60.26M | 37.86M |
| Cash | 28.32M | 471.07M | 55.70M | 95.09M | 130.88M |
| Cash and equivalents | - | - | - | - | 130.88M |
| Total current liabilities | 1111.92M | 571.56M | 200.35M | 74.43M | 32.48M |
| Net debt | 1050.40M | 776.67M | 857.60M | 730.93M | 409.61M |
| Short term debt | 1015.51M | 487.47M | 105.64M | 51.56M | 3.01M |
| Short long term debt | 1013.74M | - | 104.46M | 49.78M | - |
| Short long term debt total | 1078.72M | 1247.74M | 913.31M | 826.02M | 540.48M |
| Other stockholder equity | 27.26M | 0.00M | 21.70M | 11.95M | 9.10M |
| Property plant equipment | - | - | - | - | 475.56M |
| Total current assets | 113.15M | 599.13M | 171.53M | 156.38M | 154.79M |
| Net tangible assets | - | - | - | 145.28M | 94.25M |
| Short term investments | 2.14M | - | - | - | 0.00M |
| Net receivables | 8.44M | 38.68M | 8.80M | 27.02M | 7.59M |
| Long term debt | 53.20M | - | 806.56M | 773.06M | 534.29M |
| Inventory | 3.20M | 2.07M | 0.15M | - | - |
| Accounts payable | 70.21M | 82.27M | 71.07M | 6.22M | 3.98M |
| Accumulated other comprehensive income | - | 27.07M | - | - | - |
| Non currrent assets other | 60.76M | 150.66M | 62.53M | 3.74M | 2.89M |
| Non current assets total | 2236.02M | 2110.00M | 1729.36M | 1008.32M | 625.58M |
| Capital lease obligations | 11.78M | - | 2.29M | 3.18M | 6.19M |
| Long term debt total | - | - | - | - | 537.48M |
| Breakdown | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 | 2021-02-28 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-02-28 | 2024-02-29 | 2023-02-28 | 2022-02-28 | 2021-02-28 |
| Investments | -99.94M | - | -440.78M | -306.96M | -196.34M |
| Change to liabilities | - | - | - | -2.67M | 14.17M |
| Total cashflows from investing activities | -99.94M | - | -440.78M | -306.96M | -196.34M |
| Net borrowings | -145.67M | - | - | - | 213.76M |
| Total cash from financing activities | -202.96M | 773.72M | 470.93M | 347.23M | 213.76M |
| Net income | -246.93M | -110.27M | -36.43M | -42.30M | -50.79M |
| Change in cash | -442.76M | 415.37M | -39.38M | -35.79M | -10.09M |
| Begin period cash flow | 471.07M | 55.70M | 95.09M | 130.88M | 140.97M |
| End period cash flow | 28.32M | 471.07M | 55.70M | 95.09M | 130.88M |
| Total cash from operating activities | -139.85M | -53.85M | -70.60M | -79.17M | -24.49M |
| Issuance of capital stock | 39.32M | - | 573.91M | 113.11M | 56.76M |
| Depreciation | 62.56M | 20.71M | 5.41M | 5.52M | 4.74M |
| Other cashflows from investing activities | 5.54M | - | 0.06M | 0.00M | -10.05M |
| Change to inventory | -1.12M | -1.93M | -0.15M | 0.00M | - |
| Change to account receivables | 14.73M | -6.09M | -4.46M | -19.26M | -1.99M |
| Sale purchase of stock | 39.32M | - | 573.91M | 113.11M | 0.00M |
| Other cashflows from financing activities | -96.60M | 506.69M | -46.88M | 265.40M | 216.28M |
| Change to netincome | - | - | - | - | 1.21M |
| Capital expenditures | 132.12M | 221.87M | 440.84M | 306.96M | 186.29M |
| Change in working capital | 6.17M | -2.42M | 3.82M | -21.93M | 12.19M |
| Stock based compensation | 3.12M | 8.07M | 10.28M | 3.12M | 1.80M |
| Other non cash items | 35.24M | 30.07M | -3.02M | 1.76M | -2.58M |
| Free cash flow | -271.98M | -275.72M | -511.43M | -386.13M | -210.77M |
Sector: Energy Industry: Oil & Gas E&P
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| WDS Woodside Energy Group Ltd |
0.01 0.03% |
30.91 | 12.91 | 9.64 | 4.20 | 1.20 | 3.80 | 5.59 |
| STO Santos Ltd |
0.10 1.15% |
8.80 | 25.94 | 8.67 | 4.14 | 1.31 | 5.35 | 8.33 |
| BPT Beach Energy Ltd |
- -% |
0.91 | 7.58 | 4.68 | 1.09 | 0.64 | 1.31 | 2.67 |
| TBN Tamboran Resources Corporation |
0.01 2.44% |
0.21 | - | - | 1219.70 | 1.26 | - | -10.29 |
Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 7, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc.
| Name | Title | Year Born |
|---|---|---|
| Mr. Stefano Marani | MD, CEO & Exec. Director | 1978 |
| Mr. Brian Harvey BCom (Hons), BTech Mech, CA(SA) | CFO & Director | 1975 |
| Mr. Nicholas Michael Mitchell | COO & Exec. Director | 1980 |
| Mr. Johann H. J. Weideman | Prescribed Officer | NA |
| Mr. Khalid Patel | Prescribed Officer | NA |
| Mandy-Leigh Stuart | Prescribed Officer | NA |
| Nalanie Naidu | Prescribed Officer | NA |
| Mr. Muhammed Khan | Prescribed Officer | NA |
| Mr. Reginald Edmond Cooke | Consultant | 1975 |
| Mr. Stefano Marani | MD, CEO & Executive Director | 1978 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.